At a glance
- Originator Shionogi
- Class Antihypertensives
- Mechanism of Action Angiotensin type 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 30 Jun 1998 Discontinued-Preclinical for Hypertension in Japan (Unknown route)
- 18 Aug 1995 New profile
- 18 Aug 1995 Preclinical development for Hypertension in Japan (Unknown route)